Genomictree Inc
KOSDAQ:228760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genomictree Inc
KOSDAQ:228760
|
KR |
|
Hilltop Holdings Inc
NYSE:HTH
|
US |
|
ING Groep NV
NYSE:ING
|
NL |
|
Boston Beer Company Inc
NYSE:SAM
|
US |
|
Kyowa Kirin Co Ltd
TSE:4151
|
JP |
|
Belden Inc
NYSE:BDC
|
US |
|
A
|
Alphabet Inc
SWB:ABEC
|
US |
|
E
|
E Xim IT SA
WSE:EXM
|
PL |
|
Toro Co
F:TO2
|
US |
|
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
|
UK |
|
P
|
Pentanet Ltd
ASX:5GG
|
AU |
|
E
|
EDP Renovaveis SA
F:EDW
|
ES |
|
S
|
Simco Songda JSC
VN:SDA
|
VN |
|
R
|
Renault SA
OTC:RNSDF
|
FR |
|
V
|
Versant Media Group Inc
NASDAQ:VSNT
|
US |
|
B
|
Banco Santander SA
WSE:SAN
|
ES |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
HK |
|
C
|
Campbell's Co
F:CSC
|
US |
Bankruptcy Probability
Genomictree Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genomictree Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
Genomictree Inc
KOSDAQ:228760
|
312.5B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
228B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
76.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genomictree Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genomictree Inc has total debt of 11.1m KRW. This includes both short-term (0 KRW) and long-term (11.1m KRW) debt.
You can find a full breakdown on its Balance Sheet.